HOUSTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24GMDA&src=ctag" target="_blank"gt;$GMDAlt;/agt;–Gamida Cell announced that translational data from the completed Phase 1/2 clinical study of NiCord® were reported at the 2019 TCT Annual Meeting.

Source link